Why ACCESS?
Childhood cancers are a complex set of diseases.
Despite significant scientific advances, challenges in diagnosis, treatment, long-term effects, and survivorship care remain. These challenges stem from an incomplete understanding of the biological and genetic foundations of childhood cancers, a regulatory system not designed for pediatric drug and technology development, insufficient clinical trials support, slow adoption of innovation, and inconsistent standards of care across the country.
ACCESS is well positioned to significantly change the outcome of cancer for children and their families in Canada. A national network built on scientific excellence and a team science approach is accelerating research across the patient journey, supporting collaborative research infrastructure, and building expert capacity to ensure data and discoveries are shared and innovations reach patients sooner.
The work of ACCESS benefits patients, families and the economy. This unique network positions Canada as a leader in the fight against childhood cancer by attracting and retaining top experts and talent, building the data and clinical trial capacity required to translate discoveries into economic growth, and reducing the long-term burden of disease on families and the healthcare system.
Purpose:
To ensure that every child with cancer in Canada has access to the latest scientific advances, diagnostic tools, innovative therapies and supportive care leading to better health outcomes and quality of life.
Our work is two-fold:
- Establish and lead a multi-stakeholder pan-Canadian pediatric cancer network.
- Support research in all phases of the pediatric cancer journey.
